Geron reported $390K in Ordinary Share Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ordinary Share Capital Change
Cti Biopharma CTIC:US USD 131K 4K
Cytokinetics CYTK:US USD 94K 1000
Esperion Therapeutics ESPR:US USD 75K 3K
Exelixis EXEL:US USD 324K 1000
Genmab GEN:DC DKK 66M 0
Geron GERN:US USD 390K 8K
Macrogenics MGNX:US USD 617K 2K
Novartis NOVN:VX USD 890M 0
Novavax NVAX:US USD 868K 76K
Pain Therapeutics PTIE:US USD 42K 2K
Seattle Genetics SGEN:US USD 187K 2K